Literature DB >> 21257958

DAP12 promotes IRAK-M expression and IL-10 production by liver myeloid dendritic cells and restrains their T cell allostimulatory ability.

Tina L Sumpter1, Vignesh Packiam, Heth R Turnquist, Antonino Castellaneta, Osamu Yoshida, Angus W Thomson.   

Abstract

Freshly isolated hepatic dendritic cells (DC) are comparatively immature, relatively resistant to maturation, and can downmodulate effector T cell responses. Molecular mechanisms that underlie these properties are ill defined. DNAX-activating protein of 12 kDa (DAP12) is an ITAM-bearing transmembrane adaptor protein that integrates signals through several receptors, including triggering receptor expressed on myeloid cells-1, -2, and CD200R. Notably, DC propagated from DAP12-deficient mice exhibit enhanced maturation in response to TLR ligation. Given the constitutive exposure of liver DC to endotoxin draining from the gut, we hypothesized that DAP12 might regulate liver DC maturation. We show that DAP12 is expressed by freshly isolated liver, spleen, kidney, and lung myeloid DC. Moreover, inhibition of DAP12 expression by liver DC using small interfering RNA promotes their phenotypic and functional maturation, resulting in enhanced TNF-α, IL-6, and IL-12p70 production, reduced secretion of IL-10, and enhanced CD4(+) and CD8(+) T cell proliferation. Furthermore, DAP12 silencing correlates with decreased STAT3 phosphorylation in mature liver DC and with diminished expression of the IL-1R-associated kinase-M, a negative regulator of TLR signaling. These findings highlight a regulatory role for DAP12 in hepatic DC maturation, and suggest a mechanism whereby this function may be induced/maintained.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21257958      PMCID: PMC3805281          DOI: 10.4049/jimmunol.1000527

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  82 in total

1.  Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12.

Authors:  Jessica A Hamerman; Nadia K Tchao; Clifford A Lowell; Lewis L Lanier
Journal:  Nat Immunol       Date:  2005-05-15       Impact factor: 25.606

Review 2.  Negative regulation of toll-like receptor-mediated immune responses.

Authors:  Foo Y Liew; Damo Xu; Elizabeth K Brint; Luke A J O'Neill
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

3.  Pulmonary immunity to viral infection: adenovirus infection of lung dendritic cells renders T cells nonresponsive to interleukin-2.

Authors:  Allison T Thiele; Tina L Sumpter; Joanna A Walker; Qi Xu; Cheong-Hee Chang; Robert L Bacallao; Rajesh Kher; David S Wilkes
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12.

Authors:  Ciriana Orabona; Elena Tomasello; Francesca Fallarino; Roberta Bianchi; Claudia Volpi; Silvia Bellocchio; Luigina Romani; Maria C Fioretti; Eric Vivier; Paolo Puccetti; Ursula Grohmann
Journal:  Eur J Immunol       Date:  2005-11       Impact factor: 5.532

5.  Activation of dendritic cells via inhibition of Jak2/STAT3 signaling.

Authors:  Yulia Nefedova; Pingyan Cheng; Daniele Gilkes; Michelle Blaskovich; Amer A Beg; Said M Sebti; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

Review 6.  KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions.

Authors:  Elena Tomasello; Eric Vivier
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

7.  Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance.

Authors:  Andreas Limmer; Jutta Ohl; Gerhard Wingender; Martina Berg; Frank Jüngerkes; Beatrix Schumak; Dominik Djandji; Kai Scholz; Alexandra Klevenz; Silke Hegenbarth; Frank Momburg; Günter J Hämmerling; Bernd Arnold; Percy A Knolle
Journal:  Eur J Immunol       Date:  2005-10       Impact factor: 5.532

8.  DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection.

Authors:  Hanna Sjölin; Scott H Robbins; Gilles Bessou; Asa Hidmark; Elena Tomasello; Maria Johansson; Håkan Hall; Férose Charifi; Gunilla B Karlsson Hedestam; Christine A Biron; Klas Kärre; Petter Höglund; Eric Vivier; Marc Dalod
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 9.  Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

Authors:  Maria Grazia Roncarolo; Silvia Gregori; Manuela Battaglia; Rosa Bacchetta; Katharina Fleischhauer; Megan K Levings
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

10.  DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis.

Authors:  Isaiah R Turnbull; Jonathan E McDunn; Toshiyuki Takai; R Reid Townsend; J Perren Cobb; Marco Colonna
Journal:  J Exp Med       Date:  2005-08-01       Impact factor: 14.307

View more
  19 in total

1.  Pulmonary M. tuberculosis infection delays Th1 immunity via immunoadaptor DAP12-regulated IRAK-M and IL-10 expression in antigen-presenting cells.

Authors:  M Jeyanathan; S McCormick; R Lai; S Afkhami; C R Shaler; C N Horvath; D Damjanovic; A Zganiacz; N Barra; A Ashkar; M Jordana; N Aoki; Z Xing
Journal:  Mucosal Immunol       Date:  2013-10-30       Impact factor: 7.313

2.  Hepatic antigen-presenting cells and regulation of liver transplant outcome.

Authors:  Angus W Thomson; David A Geller; Chandrashekhar Gandhi; Noriko Murase; A Jake Demetris; Donna Beer-Stolz
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

3.  O-Acetylation of Peptidoglycan Limits Helper T Cell Priming and Permits Staphylococcus aureus Reinfection.

Authors:  Marisel Sanchez; Stacey L Kolar; Sabrina Müller; Christopher N Reyes; Andrea J Wolf; Chihiro Ogawa; Rajat Singhania; Daniel D De Carvalho; Moshe Arditi; David M Underhill; Gislâine A Martins; George Y Liu
Journal:  Cell Host Microbe       Date:  2017-09-21       Impact factor: 21.023

4.  IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells.

Authors:  Benjamin M Matta; Giorgio Raimondi; Brian R Rosborough; Tina L Sumpter; Angus W Thomson
Journal:  J Immunol       Date:  2012-04-16       Impact factor: 5.422

Review 5.  The role of hepatic immune regulation in systemic immunity to viral infection.

Authors:  Percy A Knolle; Jan Böttcher; Li-Rung Huang
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

6.  DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance.

Authors:  O Yoshida; S Kimura; L Dou; B M Matta; S Yokota; M A Ross; D A Geller; A W Thomson
Journal:  Am J Transplant       Date:  2014-06-16       Impact factor: 8.086

7.  Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells.

Authors:  H Zhang; D B Stolz; G Chalasani; A W Thomson
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

8.  Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO.

Authors:  Tina L Sumpter; Anil Dangi; Benjamin M Matta; Chao Huang; Donna B Stolz; Yoram Vodovotz; Angus W Thomson; Chandrashekhar R Gandhi
Journal:  J Immunol       Date:  2012-09-07       Impact factor: 5.422

9.  CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice.

Authors:  Osamu Yoshida; Shoko Kimura; Edwin K Jackson; Simon C Robson; David A Geller; Noriko Murase; Angus W Thomson
Journal:  Hepatology       Date:  2013-10-15       Impact factor: 17.425

Review 10.  Liver transplantation in the mouse: Insights into liver immunobiology, tissue injury, and allograft tolerance.

Authors:  Shinichiro Yokota; Osamu Yoshida; Yoshihiro Ono; David A Geller; Angus W Thomson
Journal:  Liver Transpl       Date:  2016-04       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.